Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results.

Autor:	Kumar, Princy1 kumarp@gunet.georgetown.edu, DeJesus, Edwin2, Huhn, Gregory3, Sloan, Louis4, Butkus Small, Catherine5, Edelstein, Howard6, Felizarta, Franco7, Hao, Ritche8, Ross, Lisa9, Stancil, Britt10, Pappa, Keith10, Ha, Belinda9
Zdroj:	BMC Infectious Diseases. 2013, Vol. 13 Issue 1, p1-11. 11p. 3 Charts, 3 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu